{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:16:53Z","timestamp":1794493013558,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The association between impaired lung function and mortality has been well documented in the general population of Western European countries. We assessed the risk of death associated with reduced spirometry indices among people from four Central and Eastern European countries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This prospective population-based cohort includes men and women aged 45\u201369\u00a0years, residents in urban settlements in Czech Republic, Poland, Russia and Lithuania, randomly selected from population registers. The baseline survey in 2002\u20132005 included 36,106 persons of whom 24,993 met the inclusion criteria. Cox proportional hazards models were used to estimate the hazard ratios of mortality over 11\u201316\u00a0years of follow-up for mild, moderate, moderate-severe and very severe lung function impairment categories.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>After adjusting for covariates, mild (hazard ratio (HR): 1.25; 95% CI 1.15\u20121.37) to severe (HR: 3.35; 95% CI 2.62\u20124.27) reduction in FEV1 was associated with an increased risk of death according to degree of lung impairment, compared to people with normal lung function. The association was only slightly attenuated but remained significant after exclusion of smokers and participants with previous history of respiratory diseases. The HRs varied between countries but not statistically significant; the highest excess risk among persons with more severe impairment was seen in Poland (HR: 4.28, 95% CI 2.14\u20128.56) and Lithuania (HR: 4.07, 95% CI 2.21\u20127.50).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Reduced FEV1 is an independent predictor of all-cause mortality, with risk increasing with the degree of lung function impairment and some country-specific variation between the cohorts.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12931-022-02057-y","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T07:05:37Z","timestamp":1653980737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impaired lung function and mortality in Eastern Europe: results from multi-centre cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Tatyana","family":"Court","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadezda","family":"Capkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Paj\u0105k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Malyutina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Simonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdonas","family":"Tamosiunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bob\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hynek","family":"Pikhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"issue":"1","key":"2057_CR1","doi-asserted-by":"crossref","first-page":"11862","DOI":"10.1038\/s41598-020-68372-w","volume":"10","author":"G Weinmayr","year":"2020","unstructured":"Weinmayr G, et al. Association of lung function with overall mortality is independent of inflammatory, cardiac, and functional biomarkers in older adults: the ActiFE-study. Sci Rep. 2020;10(1):11862.","journal-title":"Sci Rep"},{"issue":"7","key":"2057_CR2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/oem.2006.031419","volume":"64","author":"K Sircar","year":"2007","unstructured":"Sircar K, et al. Decline in lung function and mortality: implications for medical monitoring. Occup Environ Med. 2007;64(7):461\u20136.","journal-title":"Occup Environ Med"},{"issue":"2","key":"2057_CR3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4187\/respcare.07012","volume":"65","author":"CA Vaz Fragoso","year":"2020","unstructured":"Vaz Fragoso CA, Van Ness PH, McAvay GJ. FEV(1) as a standalone spirometric predictor and the attributable fraction for death in older persons. Respir Care. 2020;65(2):217\u201326.","journal-title":"Respir Care"},{"issue":"5","key":"2057_CR4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thorax.58.5.388","volume":"58","author":"DM Mannino","year":"2003","unstructured":"Mannino DM, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003;58(5):388\u201393.","journal-title":"Thorax"},{"issue":"1","key":"2057_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/15412555.2013.781578","volume":"11","author":"L Leivseth","year":"2014","unstructured":"Leivseth L, et al. Lung function and respiratory symptoms in association with mortality: the HUNT Study. COPD. 2014;11(1):59\u201380.","journal-title":"COPD"},{"issue":"6","key":"2057_CR6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00420-012-0803-3","volume":"86","author":"T Vehmas","year":"2013","unstructured":"Vehmas T, Pallasaho P, Piirila P. Lung function predicts mortality: 10-year follow-up after lung cancer screening among asbestos-exposed workers. Int Arch Occup Environ Health. 2013;86(6):667\u201372.","journal-title":"Int Arch Occup Environ Health"},{"issue":"11","key":"2057_CR7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10654-006-9057-2","volume":"21","author":"GD Batty","year":"2006","unstructured":"Batty GD, et al. Adult height and lung function as markers of life course exposures: Associations with risk factors and cause-specific mortality. Eur J Epidemiol. 2006;21(11):795\u2013801.","journal-title":"Eur J Epidemiol"},{"issue":"12","key":"2057_CR8","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10654-012-9750-2","volume":"27","author":"P Baughman","year":"2012","unstructured":"Baughman P, et al. Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol. 2012;27(12):933\u201343.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"2057_CR9","doi-asserted-by":"crossref","first-page":"e015381","DOI":"10.1136\/bmjopen-2016-015381","volume":"7","author":"RP Gupta","year":"2017","unstructured":"Gupta RP, Strachan DP. Ventilatory function as a predictor of mortality in lifelong non-smokers: evidence from large British cohort studies. BMJ Open. 2017;7(7):e015381.","journal-title":"BMJ Open"},{"issue":"12","key":"2057_CR10","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/aje\/kwq294","volume":"172","author":"S Sabia","year":"2010","unstructured":"Sabia S, et al. Why does lung function predict mortality? Results from the Whitehall II Cohort Study. Am J Epidemiol. 2010;172(12):1415\u201323.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"2057_CR11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10654-013-9800-4","volume":"28","author":"DW Loth","year":"2013","unstructured":"Loth DW, et al. Normal spirometry values in healthy elderly: the Rotterdam Study. Eur J Epidemiol. 2013;28(4):329\u201334.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"2057_CR12","doi-asserted-by":"crossref","first-page":"E613","DOI":"10.1016\/S2214-109X(19)30070-1","volume":"7","author":"M Duong","year":"2019","unstructured":"Duong M, et al. Mortality and cardiovascular and respiratory morbidity in individuals with impaired FEV1 (PURE): an international, community-based cohort study. Lancet Glob Health. 2019;7(5):E613\u201323.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"2057_CR13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","volume":"203","author":"DMG Halpin","year":"2021","unstructured":"Halpin DMG, et al. Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203(1):24\u201336.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"2057_CR14","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","volume":"40","author":"PH Quanjer","year":"2012","unstructured":"Quanjer PH, et al. Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324\u201343.","journal-title":"Eur Respir J"},{"issue":"1","key":"2057_CR15","doi-asserted-by":"crossref","first-page":"e000575","DOI":"10.1136\/bmjresp-2020-000575","volume":"7","author":"KP Sylvester","year":"2020","unstructured":"Sylvester KP, et al. ARTP statement on pulmonary function testing 2020. Bmj Open Respir Res. 2020;7(1):e000575.","journal-title":"Bmj Open Respir Res"},{"issue":"5","key":"2057_CR16","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1183\/09031936.00100313","volume":"43","author":"MR Miller","year":"2014","unstructured":"Miller MR, et al. Best lung function equations for the very elderly selected by survival analysis. Eur Respir J. 2014;43(5):1338\u201346.","journal-title":"Eur Respir J"},{"key":"2057_CR17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1471-2458-6-255","volume":"6","author":"A Peasey","year":"2006","unstructured":"Peasey A, et al. Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: rationale and design of the HAPIEE study. BMC Public Health. 2006;6:255.","journal-title":"BMC Public Health"},{"issue":"4","key":"2057_CR18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/jech-2013-203057","volume":"68","author":"H Vandenheede","year":"2014","unstructured":"Vandenheede H, et al. Socioeconomic inequalities in all-cause mortality in the Czech Republic, Russia, Poland and Lithuania in the 2000s: findings from the HAPIEE Study. J Epidemiol Community Health. 2014;68(4):297\u2013303.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"2057_CR19","doi-asserted-by":"crossref","first-page":"e022638","DOI":"10.1136\/bmjopen-2018-022638","volume":"9","author":"M Polak","year":"2019","unstructured":"Polak M, et al. Socioeconomic status and pulmonary function, transition from childhood to adulthood: cross-sectional results from the polish part of the HAPIEE study. BMJ Open. 2019;9(1):e022638.","journal-title":"BMJ Open"},{"issue":"8","key":"2057_CR20","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, et al. Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med. 2019;200(8):E70\u201388.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2057_CR21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179\u201387.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"2057_CR22","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1513\/AnnalsATS.201802-104OC","volume":"15","author":"MJ Hegewald","year":"2018","unstructured":"Hegewald MJ, et al. Airflow obstruction categorization methods and mortality. Ann Am Thorac Soc. 2018;15(8):920\u20135.","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"2057_CR23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1183\/09031936.00086313","volume":"43","author":"PH Quanjer","year":"2014","unstructured":"Quanjer PH, et al. Grading the severity of airways obstruction: new wine in new bottles. Eur Respir J. 2014;43(2):505\u201312.","journal-title":"Eur Respir J"},{"issue":"1","key":"2057_CR24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/jech-2020-214050","volume":"75","author":"YB Zhang","year":"2021","unstructured":"Zhang YB, et al. Combined lifestyle factors, all-cause mortality and cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies. J Epidemiol Community Health. 2021;75(1):92\u20139.","journal-title":"J Epidemiol Community Health"},{"issue":"9993","key":"2057_CR25","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(15)60175-1","volume":"386","author":"A Ganna","year":"2015","unstructured":"Ganna A, Ingelsson E. 5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study. Lancet. 2015;386(9993):533\u201340.","journal-title":"Lancet"},{"issue":"2","key":"2057_CR26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.npp.1300030","volume":"28","author":"JF Etter","year":"2003","unstructured":"Etter JF, Le Houezec J, Perneger TV. A self-administered questionnaire to measure dependence on cigarettes: the Cigarette Dependence Scale. Neuropsychopharmacology. 2003;28(2):359\u201370.","journal-title":"Neuropsychopharmacology"},{"key":"2057_CR27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/1471-2458-9-439","volume":"9","author":"S Boylan","year":"2009","unstructured":"Boylan S, et al. Dietary habits in three Central and Eastern European countries: the HAPIEE study. BMC Public Health. 2009;9:439.","journal-title":"BMC Public Health"},{"issue":"1","key":"2057_CR28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1378\/chest.11-0797","volume":"141","author":"DM Mannino","year":"2012","unstructured":"Mannino DM, Diaz-Guzman E. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality. Chest. 2012;141(1):73\u201380.","journal-title":"Chest"},{"issue":"9","key":"2057_CR29","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1253\/circj.CJ-14-0308","volume":"78","author":"KB Min","year":"2014","unstructured":"Min KB, Min JY. Reduced lung function, c-reactive protein, and increased risk of cardiovascular mortality. Circ J. 2014;78(9):2309-U423.","journal-title":"Circ J"},{"issue":"9","key":"2057_CR30","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/oby.2006.190","volume":"14","author":"WY Lin","year":"2006","unstructured":"Lin WY, et al. Impaired lung function is associated with obesity and metabolic syndrome in adults. Obesity. 2006;14(9):1654\u201361.","journal-title":"Obesity"},{"key":"2057_CR31","doi-asserted-by":"crossref","first-page":"903","DOI":"10.2147\/COPD.S148421","volume":"13","author":"DK Oh","year":"2018","unstructured":"Oh DK, et al. Comparison of the fixed ratio and the Z-score of FEV1\/FVC in the elderly population: a long-term mortality analysis from the Third National Health and Nutritional Examination Survey. Int J Chron Obstruct Pulmon Dis. 2018;13:903\u201315.","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02057-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02057-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02057-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T16:51:27Z","timestamp":1743871887000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02057-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2057"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02057-y","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,31]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent. The study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Joint UCL\/UCLH Committees on the Ethics of Human Research (Committee Alpha), reference 99\/0081; the Ethical Committee of the Institute of Internal Medicine, Siberian Branch of the Russian Academy of Medical Sciences, March 14, 2002 (Protocol No. 1); the Ethics Committee of the Kaunas Medical University (reference P1-09\/2005); and Ethics Committee at the National Institute of Public Health, Prague (reference 2002-01-08\/P1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}